Complete Clinical Response to Cetuximab in a Patient with Metastatic Cutaneous Squamous Cell Carcinoma

Author： MILLER KRISTEN   SHERMAN WILLIAM   RATNER DÉSIRÉE  

Publisher： Elsevier

ISSN： 1076-0512

Source： Dermatologic Surgery, Vol.36, Iss.12, 2010-12, pp. : 2069-2074

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Phase 1 and pharmacokinetic study of everolimus in combination with cetuximab and carboplatin for recurrent/metastatic squamous cell carcinoma of the head and neck

By  

Cancer, Vol. 120, Iss. 24, 2014-12 ,pp. : 3940-3951

Blackwell Publishing

Access to resources Recommend Favorite

Cetuximab for Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck: A NICE Single Technology Appraisal

By Bagust Adrian  

PharmacoEconomics, Vol. 28, Iss. 6, 2010-06 ,pp. : 439-448

Adis International

Access to resources Recommend Favorite

Cetuximab: A Review of its Use in Squamous Cell Carcinoma of the Head and Neck and Metastatic Colorectal Cancer

By Blick Stephanie K.A.   Scott Lesley J.  

Drugs, Vol. 67, Iss. 17, 2007-01 ,pp. : 2585-2607

Adis International

Access to resources Recommend Favorite

A Novel Treatment Approach for Extensive, Eruptive, Cutaneous Squamous Cell Carcinomas in a Patient Receiving BRAF Inhibitor Therapy for Metastatic Melanoma

By Fathi Ramin   Kamalpour Loebat   Gammon Bryan   Tung Rebecca  

Dermatologic Surgery, Vol. 39, Iss. 2, 2013-02 ,pp. : 341-344

Elsevier

Access to resources Recommend Favorite

Response to Sorafenib in a Patient with Metastatic Xp11 Translocation Renal Cell Carcinoma

By Hou Ming-Mo  

Clinical Drug Investigation, Vol. 30, Iss. 11, 2010-11 ,pp. : 799-804

Adis International

Access to resources Recommend Favorite